Search research articles
Contact Us
Filters
Showing results (61-70 of 97) with videos related to
Page
of 10
Sort By:
Vaccine
|
May 26, 2022
Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework
Ekkehard Beck, Eliana Biundo, Nancy Devlin, et al.
The Pediatric Infectious Disease Journal
|
November 12, 2010
Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of age
Robert Booy, Peter Richmond, Terry Nolan, et al.
Pediatrics
|
September 5, 2006
Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age
Terry Nolan, Henry Bernstein, Mark M Blatter, et al.
Vaccine
|
September 3, 2024
Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents
Peter Richmond, Terry Nolan, Anthony McGirr, et al.
The Journal of Infectious Diseases
|
October 24, 2007
Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine
Anna R Giuliano, Eduardo Lazcano-Ponce, Luisa Villa, et al.
Aging Clinical and Experimental Research
|
January 10, 2022
Improving vaccination rates in older adults and at-risk groups: focus on pertussis
Jung-Hyun Choi, Jaime Correia de Sousa, Monica Fletcher, et al.
Pediatrics
|
March 4, 2008
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age
Terry Nolan, David I Bernstein, Stan L Block, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2018
The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study
Lisa McHugh, Helen S Marshall, Kirsten P Perrett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 26, 2024
Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical Study
Terry Nolan, Chiranjiwi Bhusal, Alejandro Hoberman, et al.
Vaccine
|
May 21, 2022
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts
Maarten Postma, Eliana Biundo, Annie Chicoye, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 97) with videos related to
Sort By:
Page
of 10
Vaccine
|
May 26, 2022
Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework
Ekkehard Beck, Eliana Biundo, Nancy Devlin, et al.
The Pediatric Infectious Disease Journal
|
November 12, 2010
Immediate and longer term immunogenicity of a single dose of the combined haemophilus influenzae type B-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in primed toddlers 12 to 18 months of age
Robert Booy, Peter Richmond, Terry Nolan, et al.
Pediatrics
|
September 5, 2006
Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age
Terry Nolan, Henry Bernstein, Mark M Blatter, et al.
Vaccine
|
September 3, 2024
Phase 1 trial of an investigational Tdap booster vaccine with CpG 1018 adjuvant compared with Boostrix in healthy adults and adolescents
Peter Richmond, Terry Nolan, Anthony McGirr, et al.
The Journal of Infectious Diseases
|
October 24, 2007
Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine
Anna R Giuliano, Eduardo Lazcano-Ponce, Luisa Villa, et al.
Aging Clinical and Experimental Research
|
January 10, 2022
Improving vaccination rates in older adults and at-risk groups: focus on pertussis
Jung-Hyun Choi, Jaime Correia de Sousa, Monica Fletcher, et al.
Pediatrics
|
March 4, 2008
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age
Terry Nolan, David I Bernstein, Stan L Block, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 27, 2018
The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study
Lisa McHugh, Helen S Marshall, Kirsten P Perrett, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 26, 2024
Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical Study
Terry Nolan, Chiranjiwi Bhusal, Alejandro Hoberman, et al.
Vaccine
|
May 21, 2022
Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts
Maarten Postma, Eliana Biundo, Annie Chicoye, et al.
Page
of 10